Regulators and physicians are hoping to limit the use of a new weight loss pill that carries heightened safety risks to patients, according to a Fox News report.
Millions of overweight Americans have begun taking Qnexa, an obesity drug that increases the chances of birth defects and heart problems in those who take it.
Regulators are working to develop restrictive standards to exclude pregnant women from taking the drug and hope to provide a training program for physicians and limit distribution of the pill to certified mail order pharmacies.
Stony Brook University Medical Center Opens New Bariatric and Metabolic Center
Chronic Kidney Disease Patients Can Safely Undergo Bariatric Surgery, Study Says
Millions of overweight Americans have begun taking Qnexa, an obesity drug that increases the chances of birth defects and heart problems in those who take it.
Regulators are working to develop restrictive standards to exclude pregnant women from taking the drug and hope to provide a training program for physicians and limit distribution of the pill to certified mail order pharmacies.
Related Articles on GI and Endoscopy:
Dr. Joseph Brasco: 5 Points on Fecal Microbiota Transplant in an ASCStony Brook University Medical Center Opens New Bariatric and Metabolic Center
Chronic Kidney Disease Patients Can Safely Undergo Bariatric Surgery, Study Says